vs
Side-by-side financial comparison of John Marshall Bancorp, Inc. (JMSB) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $16.8M, roughly 1.1× John Marshall Bancorp, Inc.). John Marshall Bancorp, Inc. runs the higher net margin — 36.3% vs -3.0%, a 39.4% gap on every dollar of revenue. Over the past eight quarters, John Marshall Bancorp, Inc.'s revenue compounded faster (15.3% CAGR vs -10.1%).
John Marshall Bancorp, Inc. is a U.S.-based bank holding company that operates through its wholly owned subsidiary John Marshall Bank. It provides a full suite of commercial and consumer banking products including deposit accounts, commercial loans, residential mortgages, and personal financial services, primarily serving retail customers and small-to-mid-sized businesses across the U.S. Mid-Atlantic region.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
JMSB vs RMTI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $16.8M | $18.3M |
| Net Profit | $6.1M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | — | -2.2% |
| Net Margin | 36.3% | -3.0% |
| Revenue YoY | — | -25.6% |
| Net Profit YoY | 26.8% | 26.7% |
| EPS (diluted) | $0.43 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $16.8M | — | ||
| Q4 25 | $16.4M | $18.3M | ||
| Q3 25 | $16.3M | $15.9M | ||
| Q2 25 | $15.4M | $16.1M | ||
| Q1 25 | $14.6M | $18.9M | ||
| Q4 24 | $14.3M | $24.7M | ||
| Q3 24 | $13.8M | $28.3M | ||
| Q2 24 | $12.6M | $25.8M |
| Q1 26 | $6.1M | — | ||
| Q4 25 | $5.9M | $-554.0K | ||
| Q3 25 | $5.4M | $-1.8M | ||
| Q2 25 | $5.1M | $-1.5M | ||
| Q1 25 | $4.8M | $-1.5M | ||
| Q4 24 | $4.8M | $-756.0K | ||
| Q3 24 | $4.2M | $1.7M | ||
| Q2 24 | $3.9M | $343.0K |
| Q1 26 | — | — | ||
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% |
| Q1 26 | — | — | ||
| Q4 25 | 47.4% | -2.2% | ||
| Q3 25 | 42.2% | -9.9% | ||
| Q2 25 | 42.7% | -8.4% | ||
| Q1 25 | 42.4% | -7.2% | ||
| Q4 24 | 42.5% | -2.1% | ||
| Q3 24 | 38.8% | 6.8% | ||
| Q2 24 | 39.7% | 2.0% |
| Q1 26 | 36.3% | — | ||
| Q4 25 | 36.2% | -3.0% | ||
| Q3 25 | 33.2% | -11.0% | ||
| Q2 25 | 33.1% | -9.3% | ||
| Q1 25 | 32.9% | -8.0% | ||
| Q4 24 | 33.3% | -3.1% | ||
| Q3 24 | 30.7% | 5.9% | ||
| Q2 24 | 30.9% | 1.3% |
| Q1 26 | $0.43 | — | ||
| Q4 25 | $0.41 | $-0.01 | ||
| Q3 25 | $0.38 | $-0.05 | ||
| Q2 25 | $0.36 | $-0.05 | ||
| Q1 25 | $0.34 | $-0.04 | ||
| Q4 24 | $0.33 | $-0.02 | ||
| Q3 24 | $0.30 | $0.04 | ||
| Q2 24 | $0.27 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $150.2M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $268.1M | $37.0M |
| Total Assets | $2.4B | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $150.2M | — | ||
| Q4 25 | $130.0M | $10.7M | ||
| Q3 25 | $163.6M | $13.6M | ||
| Q2 25 | $116.9M | $12.5M | ||
| Q1 25 | $169.1M | $11.4M | ||
| Q4 24 | $122.5M | $15.7M | ||
| Q3 24 | $177.2M | $12.3M | ||
| Q2 24 | $182.6M | $11.9M |
| Q1 26 | — | — | ||
| Q4 25 | $80.9M | — | ||
| Q3 25 | $80.9M | — | ||
| Q2 25 | $80.8M | — | ||
| Q1 25 | $80.8M | — | ||
| Q4 24 | $80.8M | — | ||
| Q3 24 | $80.8M | — | ||
| Q2 24 | $24.7M | — |
| Q1 26 | $268.1M | — | ||
| Q4 25 | $265.6M | $37.0M | ||
| Q3 25 | $259.7M | $37.0M | ||
| Q2 25 | $253.7M | $30.4M | ||
| Q1 25 | $253.0M | $31.5M | ||
| Q4 24 | $246.6M | $32.6M | ||
| Q3 24 | $243.1M | $29.1M | ||
| Q2 24 | $235.3M | $23.5M |
| Q1 26 | $2.4B | — | ||
| Q4 25 | $2.3B | $57.1M | ||
| Q3 25 | $2.3B | $57.5M | ||
| Q2 25 | $2.3B | $52.6M | ||
| Q1 25 | $2.3B | $54.0M | ||
| Q4 24 | $2.2B | $59.2M | ||
| Q3 24 | $2.3B | $57.1M | ||
| Q2 24 | $2.3B | $53.0M |
| Q1 26 | — | — | ||
| Q4 25 | 0.30× | — | ||
| Q3 25 | 0.31× | — | ||
| Q2 25 | 0.32× | — | ||
| Q1 25 | 0.32× | — | ||
| Q4 24 | 0.33× | — | ||
| Q3 24 | 0.33× | — | ||
| Q2 24 | 0.11× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $2.3M |
| Free Cash FlowOCF − Capex | — | $2.2M |
| FCF MarginFCF / Revenue | — | 12.0% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $22.6M | $2.3M | ||
| Q3 25 | $1.2M | $-1.3M | ||
| Q2 25 | $7.5M | $1.8M | ||
| Q1 25 | $7.0M | $-3.5M | ||
| Q4 24 | $17.3M | $865.0K | ||
| Q3 24 | $1.4M | $4.3M | ||
| Q2 24 | $10.2M | $1.4M |
| Q1 26 | — | — | ||
| Q4 25 | $22.0M | $2.2M | ||
| Q3 25 | $1.2M | $-1.5M | ||
| Q2 25 | $7.4M | $1.7M | ||
| Q1 25 | $6.6M | $-3.5M | ||
| Q4 24 | $16.8M | $470.0K | ||
| Q3 24 | $1.3M | $4.1M | ||
| Q2 24 | $10.1M | $1.2M |
| Q1 26 | — | — | ||
| Q4 25 | 134.7% | 12.0% | ||
| Q3 25 | 7.3% | -9.6% | ||
| Q2 25 | 47.8% | 10.5% | ||
| Q1 25 | 45.3% | -18.8% | ||
| Q4 24 | 116.9% | 1.9% | ||
| Q3 24 | 9.5% | 14.4% | ||
| Q2 24 | 80.1% | 4.5% |
| Q1 26 | — | — | ||
| Q4 25 | 3.4% | 0.5% | ||
| Q3 25 | 0.2% | 1.4% | ||
| Q2 25 | 1.0% | 1.0% | ||
| Q1 25 | 2.3% | 0.3% | ||
| Q4 24 | 3.4% | 1.6% | ||
| Q3 24 | 0.8% | 0.7% | ||
| Q2 24 | 0.4% | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | 3.82× | — | ||
| Q3 25 | 0.23× | — | ||
| Q2 25 | 1.48× | — | ||
| Q1 25 | 1.45× | — | ||
| Q4 24 | 3.61× | — | ||
| Q3 24 | 0.33× | 2.57× | ||
| Q2 24 | 2.60× | 4.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
JMSB
| Net Interest Income | $16.5M | 98% |
| Noninterest Income | $284.0K | 2% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
